UNICA IRIS Institutional Research Information System

LAI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 36.788
NA - Nord America 2.904
AS - Asia 1.478
SA - Sud America 251
Continente sconosciuto - Info sul continente non disponibili 139
AF - Africa 54
OC - Oceania 7
Totale 41.621
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 35.997
US - Stati Uniti d'America 2.756
SG - Singapore 579
CN - Cina 374
SE - Svezia 251
BR - Brasile 175
VN - Vietnam 174
GB - Regno Unito 100
DE - Germania 98
CA - Canada 87
FR - Francia 85
IN - India 70
FI - Finlandia 63
HK - Hong Kong 58
NL - Olanda 38
PL - Polonia 33
AR - Argentina 31
BD - Bangladesh 27
KR - Corea 27
IQ - Iraq 21
ZA - Sudafrica 21
ES - Italia 20
MX - Messico 20
TR - Turchia 19
CO - Colombia 18
IE - Irlanda 16
AT - Austria 15
JP - Giappone 15
ID - Indonesia 13
IR - Iran 12
UA - Ucraina 12
PH - Filippine 11
PK - Pakistan 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
IL - Israele 9
IS - Islanda 8
SA - Arabia Saudita 8
AU - Australia 7
CR - Costa Rica 7
CL - Cile 6
EC - Ecuador 6
JE - Jersey 6
JM - Giamaica 6
RU - Federazione Russa 6
TZ - Tanzania 6
VE - Venezuela 6
BE - Belgio 5
LT - Lituania 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
GR - Grecia 4
HN - Honduras 4
KE - Kenya 4
MY - Malesia 4
PR - Porto Rico 4
PY - Paraguay 4
RO - Romania 4
SV - El Salvador 4
AL - Albania 3
DK - Danimarca 3
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
PT - Portogallo 3
TH - Thailandia 3
BB - Barbados 2
BH - Bahrain 2
DM - Dominica 2
DZ - Algeria 2
GH - Ghana 2
GP - Guadalupe 2
GT - Guatemala 2
LB - Libano 2
LU - Lussemburgo 2
NO - Norvegia 2
OM - Oman 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LC - Santa Lucia 1
LV - Lettonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
NG - Nigeria 1
PE - Perù 1
RS - Serbia 1
Totale 41.480
Salva come PNG Salva come JPEG
Città #
Cagliari 34.279
Uta 1.448
Ashburn 394
Singapore 331
San Jose 241
Nyköping 164
Dallas 156
Boardman 150
Chandler 144
Fairfield 125
Beijing 99
New York 98
Los Angeles 89
Council Bluffs 64
Houston 59
Hong Kong 56
Seattle 56
Santa Clara 53
Wilmington 52
Woodbridge 47
Helsinki 44
Ho Chi Minh City 43
Rome 40
Cambridge 39
Hanoi 39
Boston 36
Lauterbourg 36
Shanghai 35
San Diego 34
Munich 27
Orem 26
The Dalles 26
Chicago 25
Frankfurt am Main 25
Hefei 25
Montreal 25
Redondo Beach 21
Milan 20
Toronto 20
Columbus 18
Seoul 18
São Paulo 18
Amsterdam 17
Chennai 17
Dong Ket 16
London 16
Buffalo 15
Denver 15
Warsaw 15
Pune 14
Stockholm 14
Nuremberg 13
Guangzhou 12
Rio de Janeiro 12
Tokyo 12
Brooklyn 11
Miami 11
Tashkent 11
Atlanta 10
St. Petersburg 10
West Lafayette 10
Ann Arbor 9
Jacksonville 9
Poznan 9
Tehran 9
Turku 9
Lappeenranta 8
Manchester 8
Mexico City 8
North Bergen 8
Reykjavik 8
Casablanca 7
Cleveland 7
Da Nang 7
Dothan 7
Durban 7
Florence 7
Johannesburg 7
Phoenix 7
Turin 7
Vancouver 7
Bari 6
Dar es Salaam 6
Dearborn 6
Dublin 6
Düsseldorf 6
Medellín 6
Málaga 6
Naples 6
Poplar 6
Portsmouth 6
Santiago de Cali 6
Selargius 6
Vienna 6
Andover 5
Baghdad 5
Casoria 5
Curitiba 5
Dubai 5
Erbil 5
Totale 39.259
Salva come PNG Salva come JPEG
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.259
Molecular-biology-driven treatment for metastatic colorectal cancer 2.794
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.732
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.393
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy 1.923
New therapeutic targets in pancreatic cancer 1.666
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 1.603
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.557
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? 1.271
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.243
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.213
null 1.080
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 1.039
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 976
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 955
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 918
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 891
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 792
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 781
Investigating the Ovarian Microstructure in the Genera Helicolenus and Scorpaena (Teleostei, Sub‐Order Scorpaenoidei) with Implications for Ovarian Dynamics and Spawning 745
Uncovering key targets of success for immunotherapy in pancreatic cancer 742
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study 716
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 694
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 665
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice 659
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma 659
BRCA-mutant pancreatic ductal adenocarcinoma 640
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 622
Immune Checkpoint Inhibitors in the Treatment of HCC 612
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 603
Soft tissue epithelioid vascular tumors: a practical clinico pathological diagnostic approach 548
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study 542
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 540
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 518
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 510
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 509
null 455
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 258
Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized Therapeutics 223
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 221
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors 208
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 153
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 134
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 122
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 120
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 117
Totale 41.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.634 0 0 0 0 152 161 141 346 263 372 436 763
2022/20236.988 748 1.210 929 547 511 612 321 464 397 432 534 283
2023/20247.807 309 210 220 303 527 997 1.040 2.373 371 314 557 586
2024/202511.291 2.841 3.154 1.215 1.382 610 973 511 70 126 123 102 184
2025/20263.799 338 206 293 374 290 298 830 337 219 352 182 80
2026/2027739 61 136 179 361 2 0 0 0 0 0 0 0
Totale 41.621